Heparin-azithromycin microparticulate nasal gels block SARS-CoV-2 and bacterial respiratory infections

Bryan J. Anaya, Karim Osouli-Bostanabad, Diego F. Tirado, Elena González-Burgos, Aikaterini Lalatsa*, Dolores R. Serrano*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Heparin-azithromycin microparticulate nasal gels block SARS-CoV-2 and bacterial respiratory infections'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology